Eric Venker
Director, Chief Executive Officer; President & Immunovant CEO · 14 filings · Latest: Oct 1, 2026
Immunovant, Inc.
Roivant Sciences Ltd.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ROIV | Venker Eric | — | Nov 20, 2024 | Proposed Sale | $11.49 | 100,000 | $1.1M | — | |
ROIV | Venker Eric | — | Nov 20, 2024 | Proposed Sale | $11.32 | 100,000 | $1.1M | — | |
ROIV | Venker Eric | — | Oct 21, 2024 | Proposed Sale | $11.65 | 100,000 | $1.2M | — |
← Previous
Page 4 of 4